Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

KineMed receives grant from Daiichi Sankyo for clinical Welchol trial in diabetes type 2

Nov. 24, 2009

Raptor completes phase II trial of delayed-release cysteamine in cystinosis

Nov. 24, 2009

GFT-505 meets all primary endpoints in phase II trial in prediabetic patients

Nov. 24, 2009

European CHMP recommends approval of Merck & Co.'s fertility treatment Elonva

Nov. 23, 2009

Sirona Biochem reports results from phase III trial of dapagliflozin in diabetes type 2

Nov. 23, 2009

Vitae discloses 11beta-HSD1 inhibitors for the treatment of diabetes

Nov. 23, 2009

Atorvastatin improves eGFR regardless of metabolic syndrome state in CHD patients

Nov. 23, 2009

Afexa Life Sciences starts clinical trial of LIP-01 for reducing blood lipids

Nov. 23, 2009

FDA grants priority review to Actelion's sNDA for miglustat in NP-C

Nov. 23, 2009

Insulin secretion stimulators described by Merck KGaA for the treatment of hyperglycemia

Nov. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...